A federal grand jury in the District of Nebraska returned 13 unsealed indictments charging 14 defendants on June 26, 2026, covering offenses ranging from drug trafficking to assaulting a federal officer [1]. The U.S. Attorney's Office for the District of Nebraska announced the charges, which include at least one count carrying a potential life sentence [1].
The most serious charge targets Peere M. Shackelford, 41, of Omaha, who faces distribution of methamphetamine and fentanyl resulting in death [1]. Under 21 U.S.C. § 841(b)(1)(C), a drug distribution conviction where death results carries a mandatory minimum of 20 years and a maximum of life imprisonment. David J. Turner, 63, of Lincoln, is charged with distributing methamphetamine and cocaine [1]. Daniel Ray Corter, 48, of Omaha, faces a charge of assaulting a federal officer with bodily injury, a felony under 18 U.S.C. § 111(b) [1]. The remaining defendants face a mix of drug distribution and related federal offenses arising from the same grand jury term [1].
The indictments reflect continued federal prioritization of fentanyl and methamphetamine trafficking prosecutions in Nebraska, a distribution corridor for controlled substances moving through the Midwest. The U.S. Attorney's Office, led by Lesley A. Woods, has maintained an active docket of grand jury referrals targeting street-level and mid-level trafficking networks [1]. Drug-death charges, while not uncommon in federal practice, require prosecutors to prove both the distribution and a direct causal link between the substance supplied and the victim's death, a burden that courts have interpreted strictly following the Supreme Court's 2014 decision in Burrage v. United States.
All 14 defendants are presumed innocent. Initial appearances and arraignments before a federal magistrate judge in the District of Nebraska are expected in the near term. The Shackelford matter will draw particular scrutiny given the drug-death allegation, which adds both elevated sentencing exposure and a more demanding evidentiary threshold at trial.